| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/23/2014 | WO2014013019A1 Novel therapeutic treatments with anti-her2 antibodies having a low fucosylation |
| 01/23/2014 | WO2014013005A1 Methods for preventing and treating chronic kidney disease (ckd) |
| 01/23/2014 | WO2014012165A1 Anti-siglec-15 antibodies |
| 01/23/2014 | WO2013169886A9 Anti-pcsk9 antibodies and use thereof |
| 01/23/2014 | WO2013165969A3 Methods and kits for diagnosing heparin-induced thrombocytopenia |
| 01/23/2014 | WO2013136186A3 Readily isolated bispecific antibodies with native immunoglobulin format |
| 01/23/2014 | WO2013009703A8 Antibodies, kit and method for detecting amyloid beta oligomers |
| 01/23/2014 | US20140026233 Transgenic pig expressing stnfr1-fc genes and the uses thereof |
| 01/23/2014 | US20140024811 Cancer detection |
| 01/23/2014 | US20140024810 Modified Antibody Compositions, Methods of Making and Using Thereof |
| 01/23/2014 | US20140024809 Hla-restricted, peptide-specific antigen binding proteins |
| 01/23/2014 | US20140024111 Host cell for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| 01/23/2014 | US20140024079 Methods for producing biological materials |
| 01/23/2014 | US20140024078 Production of proteins in glutamine-free cell culture media |
| 01/23/2014 | US20140024077 Antibody molecules having specificity for human il-6 |
| 01/23/2014 | US20140024067 KEX2 Cleavage regions of recombinant fusion proteins |
| 01/23/2014 | US20140024056 Surrogates of post-translationally modified proteins and uses thereof |
| 01/23/2014 | US20140024050 Antibodies which detect pivkaii and methods of use thereof |
| 01/23/2014 | US20140024043 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 |
| 01/23/2014 | US20140024013 Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes |
| 01/23/2014 | US20140023664 Activatable Antibodies Having Non-Binding Steric Moieties and Methods of Using the Same |
| 01/23/2014 | US20140023662 Non-antagonistic egfr-binding molecules and immunoconjugates thereof |
| 01/23/2014 | US20140023660 Anti-IL 13 Human Antibodies |
| 01/23/2014 | US20140023659 Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration |
| 01/23/2014 | US20140023652 Methods and compositions based on shiga toxin type 1 protein |
| 01/23/2014 | US20140023651 Stem cell factor inhibitor |
| 01/23/2014 | US20140023649 Antibodies that bind il-4 and/or il-13 and their uses |
| 01/23/2014 | US20140023648 Treatment of Osteoarthritis Using IL-20 Antagonists |
| 01/23/2014 | US20140023645 Engineered antibody constant domain molecules |
| 01/23/2014 | US20140023644 Antibodies Specific for TGF-Beta |
| 01/23/2014 | US20140023641 Antibody with specificity for gm-csf (i) |
| 01/23/2014 | US20140023638 Antibody to gdf8 and uses thereof |
| 01/23/2014 | US20140023637 Methods of Modifying Eukaryotic Cells |
| 01/23/2014 | US20140023592 Self coupling recombinant antibody fusion proteins |
| 01/23/2014 | CA2876787A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/23/2014 | CA2876517A1 Anti-siglec-15 antibodies |
| 01/23/2014 | CA2875486A1 Novel therapeutic treatments with anti-her2 antibodies having a low fucosylation |
| 01/22/2014 | EP2687232A1 Methods of treating systemic lupus erythematosus |
| 01/22/2014 | EP2687231A1 Composition for treatment and diagnosis of pancreatic cancer |
| 01/22/2014 | EP2687202A1 Subcutaneous anti-her2 antibody formulation |
| 01/22/2014 | EP2686682A2 Method of correlated mutational analysis to improve therapeutic antibodies |
| 01/22/2014 | EP2686444A1 Nlrp7-based diagnosis of female reproductive conditions |
| 01/22/2014 | EP2686350A1 Human tissue factor antibody and uses thereof |
| 01/22/2014 | EP2686349A2 Antibody screening methods |
| 01/22/2014 | EP2686348A1 Bi- and monospecific, asymmetric antibodies and methods of generating the same |
| 01/22/2014 | EP2686347A1 Antibodies to cd70 |
| 01/22/2014 | EP2686346A1 Diagnostic antibody assay |
| 01/22/2014 | EP2686345A1 Fc variants |
| 01/22/2014 | EP2686339A1 Novel oprf/i fusion proteins, their preparation and use |
| 01/22/2014 | EP2686334A1 Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase |
| 01/22/2014 | EP2686016A1 Antibody recognizing n-domain of midkine |
| 01/22/2014 | EP2686015A2 Overcoming resistance to erbb pathway inhibitors |
| 01/22/2014 | EP2685968A1 Compositions and methods for the therapy and diagnosis of influenza |
| 01/22/2014 | CN103534352A Method for selecting plasma cells and plasmablasts, method for producing target antigen-specific antibody, and new monoclonal antibody |
| 01/22/2014 | CN103534351A Nucleic acid construct containing nucleic acid derived from genotype 1b HCV genome, HCV genome-replicating cells transfected with same, and method for producing infectious HCV particles |
| 01/22/2014 | CN103534272A Antibody specifically recognising transferrin receptor |
| 01/22/2014 | CN103534271A Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 01/22/2014 | CN103534270A Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| 01/22/2014 | CN103534269A Compositions and methods for the alteration of XLHED phenotypes |
| 01/22/2014 | CN103534268A Antibodies |
| 01/22/2014 | CN103534264A Immunoglobulin reduced in thrombogenic agents and preparation thereof |
| 01/22/2014 | CN103533960A C-kit antibodies and uses thereof |
| 01/22/2014 | CN103533957A Humanized antibodies to LIV-1 and use of same to treat cancer |
| 01/22/2014 | CN103533956A Compositions and methods |
| 01/22/2014 | CN103533943A Prevention of adverse effects caused by cd3 specific binding domains |
| 01/22/2014 | CN103533929A Compositions and methods for the therapy and diagnosis of influenza |
| 01/22/2014 | CN103525823A Preparation method of CD20 chimeric antibody for treating urticaria |
| 01/22/2014 | CN103525772A Strain of duck viral hepatitis virus and application thereof |
| 01/22/2014 | CN103525771A Goose parvovirus and applications thereof |
| 01/22/2014 | CN103525769A Hybridoma cell capable of secreting anti retinol binding protein monoclonal antibody and application |
| 01/22/2014 | CN103525768A Anti-spring viraemia of carp virus (SVCV) monoclonal antibody 4F9, and preparation and application thereof |
| 01/22/2014 | CN103525767A Anti-infectious hematopoietic necrosis virus (IHNV) monoclonal antibody 6G7, and preparation and application thereof |
| 01/22/2014 | CN103524630A Complete antigen of OC22 polypeptide, preparation method and antibody thereof |
| 01/22/2014 | CN103524629A Complete antigen of AG22 polypeptide, preparation method and antibody thereof |
| 01/22/2014 | CN103524625A Method for generating novel induction antibody |
| 01/22/2014 | CN103524621A Anti-human CD20 chimeric monoclonal antibody |
| 01/22/2014 | CN103524620A Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 01/22/2014 | CN103524619A Antibodies directed to avss6 and uses thereof |
| 01/22/2014 | CN103524618A 促红细胞生成素受体结合抗体 Erythropoietin receptor binding antibody |
| 01/22/2014 | CN103524617A Humanized antibody against amyloid beta |
| 01/22/2014 | CN103524616A Preparation method of flavobacterium columnare polyclonal antibody |
| 01/22/2014 | CN103524615A Preparation method of anti-RHDV (Rabbit hemorrhagic disease virus) egg yolk antibody |
| 01/22/2014 | CN103524435A Hapten and complete antigen of mequindox residual marker (dedioxo mequindox) and preparation method thereof |
| 01/22/2014 | CN103524427A Preparation method as well as application of trimethoprem hapten |
| 01/22/2014 | CN103524362A Malachite green artificial antigen and antibody, and preparation method and application thereof |
| 01/22/2014 | CN103215231B Hybridoma cell strain 1H2, anti-ochratoxin A monoclonal antibody produced from same and application thereof |
| 01/21/2014 | US8633302 Variable tangential flow filtration |
| 01/21/2014 | US8633301 Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine |
| 01/21/2014 | US8633163 Template-fixed peptidomimetics |
| 01/21/2014 | US8632996 Method for producing recombinant antibody and antibody fragment thereof |
| 01/21/2014 | US8632985 Binding molecules for the treatment of myeloid cell malignancies |
| 01/21/2014 | US8632982 Biomarkers for liver injury |
| 01/21/2014 | US8632971 Methods and materials for determining the efficacy of prostate cancer therapies |
| 01/21/2014 | US8632780 Human complement C3 derivates with cobra venom factor-like function |
| 01/21/2014 | US8632779 S. aureus polypeptides and antibodies |
| 01/21/2014 | US8632778 Stabilized anti-interleukin-6 antibody-containing preparations |
| 01/21/2014 | US8632773 Antibody composition with altered Fab sialylation |
| 01/21/2014 | CA2722600C Anti-hepcidin antibodies and methods of use |
| 01/21/2014 | CA2607375C Method for the purification of antibodies |
| 01/21/2014 | CA2598561C Monoclonal antibodies against cd30 lacking in fucosyl residues |